CC Innovations

CC Innovations (CCI) promotes innovation and its commercial application. Under the leadership of Executive Director Chris Coburn, CCI helps to grow Cleveland Clinic’s innovation capacity, creates spin-off companies, licenses technology, secures resources and establishes strategic collaborations with corporate partners. Since 2000, CCI has created 30 spin-off companies, had its first IPO, sold its first spin-off in 2007, transacted more than 200 licences, filed 877 patents, issued 225 patents, and acted on 1,200 new inventions.

In 2008, CCI received and processed 203 Invention Disclosure Forms, filed 131 patents, issued 62 patents, secured 33 new license agreements, created five new companies (Cleveland Heart, Congruent Medical, OptoQuest, Perfusion Solutions, and Renovo Neural), and was awarded 4 commercialization grants from the Ohio Third Frontier Program for a total of $14 million dollars. It also held the 6th Annual Cleveland Clinic Medical Innovations Summit, welcoming more than 1,000 leaders of business, 
medicine, law and invention, and producing the widely 
noted Cleveland Clinic “Top 10 Medical Innovations” of 
the year.